SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Stateside's Canadian Microcap Board
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ayeyou who wrote (1689)9/23/2016 8:44:52 AM
From: Dave@SI  Read Replies (1) of 1728
 
BCT - New BioNap update 2016-09-22, no idea of timing relative to the buying interest also seen, I see he notes:
  • "preparing to initiate ... I/II trial in 2016Q4",
  • completing manufacturing,
  • RK Equity (in NY) and TrueNorth Lifesciences appointed,
  • predictive gene signature believed to have been found which also facilitates diagnostic for patient selection and possibly patient response monitoring in the trials (April AACR Poster),
  • "management in discussion with FDA" for trial extensions to more doses and early-stage cancer,
  • PI selected (Dr Holmes),
  • working on BriaDx.

I wonder if one of the delays is (or might be in future) getting the patient selection test sorted out? As in they will want to maximise the potential results by selecting the best patients.

At the footer he notes he is long BCT, in the last article (May) that wasn't stated.

Here's hoping!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News